Crossmark

Central effects of galcanezumab in migraine: a pilot study on Steady State Visual Evoked Potentials and occipital hemodynamic response in migraine patients

Crossref DOI link: https://doi.org/10.1186/s10194-022-01421-z

Published Online: 2022-04-29

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

de Tommaso, Marina

La Rocca, Marianna

Quitadamo, Silvia Giovanna

Ricci, Katia

Tancredi, Giusy

Clemente, Livio

Gentile, Eleonora

Ammendola, Elena

Delussi, Marianna
License Information

Text and Data Mining valid from 2022-04-29

Version of Record valid from 2022-04-29
More Information

Article History

Received: 21 March 2022

Accepted: 11 April 2022

First Online: 29 April 2022

Declarations

:

: The study was approved by the Ethic Committee of Bari Policlinico General Hospital.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below